Do cost-sharing and entry deregulation curb pharmaceutical innovation?

presented at CESifo Area Conference on Public Sector Economics, April 2011

Do cost-sharing and entry deregulation curb p ...
Volker Grossmann, Volker Gross ...
Locate

My Reading Lists:

Create a new list



Buy this book

Last edited by MARC Bot
June 30, 2022 | History

Do cost-sharing and entry deregulation curb pharmaceutical innovation?

presented at CESifo Area Conference on Public Sector Economics, April 2011

This work doesn't have a description yet. Can you add one?

Publish Date
Publisher
CESifo
Language
English
Pages
41

Buy this book

Book Details


Edition Notes

Literaturangaben. - Zusätzliches Online-Angebot unter www.SSRN.com, www.RePEc.org und www.CESifo-group.org/wp

Published in
Munich
Series
CESifo working papers -- No. 3439 : Category 1, Public finance

Classifications

Dewey Decimal Class
650, 330

The Physical Object

Pagination
41 S.
Number of pages
41

Edition Identifiers

Open Library
OL38579022M
OCLC/WorldCat
748702146
Deutsche National Bibliothek
1013105362

Work Identifiers

Work ID
OL28180903W

Community Reviews (0)

No community reviews have been submitted for this work.

Lists

History

Download catalog record: RDF / JSON
June 30, 2022 Created by MARC Bot import new book